The global mesenchymal stem cells market size is expected to reach USD 7.25 billion by 2030, according to a new study by Polaris Market Research. The report “Mesenchymal Stem Cells Market Share, Size, Trends, Industry Analysis Report, By Products & Services, By Type; By Source Of Isolation, By Indication Outlook, By Application, By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Mesenchymal tissue is adult stem cells, that can be isolated from various sources, mainly from bone marrow, and are capable to differentiate into various types of cells. These cells are mainly involved in the formation and repair of skeletal tissues and for the treatment of diseases like neurological disorders, cardiac ischemia, diabetes. Recent developments in the field of regenerative medicine due to mesenchymal stem cell-based research is expected to fuel the market. The adoption of these products along with the continuous development and improvement in the research field has accelerated the industry’s growth.
Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:
The prominent factors favoring the industry growth include an increase in the number of clinical trials, approval from regulatory bodies, multiple mesenchymal stem cells isolation sources, wide areas of application, and advancement in technology and medical innovation. The pre-clinical studies have shown that transplantation of MSC has improved cardiovascular repair along with increased apoptosis resistance, promoting the differentiation of myocardial cells, inhibiting fibrosis, reducing the level of inflammation, and promoting angiogenesis. The treatment of genetic and fatal diseases is one of the important drivers boosting market growth.
In July 2020, more than 50 clinical trials were performed using MSC for the development of therapeutics for SARS-CoV-2 infection. Key market players include Thermo Fisher Scientific; PromoCell GmbH; Axol Biosciences, Cytori Therapeutics; Cyagen Biosciences Inc.; Celprogen Inc; BrainStorm Cell; Stemedica Cell Technologies Inc; STEMCELL Technologies Inc;; Smith+Nephew; Lonza AG; ScienCell Research Laboratories; and American Type Culture Collection.
Players in the market are focused on the development of research & development (R&D) laboratories for carrying out their studies. Large companies are collaborating with various small companies and other laboratories to carry out combined research. Various funds and investments have been provided to the MSC research centers.
Polaris Market Research has segmented the mesenchymal stem cells market report based on products & services, type, source of isolation, application, and region:
Mesenchymal Stem Cells Market, Product & Service Outlook (Revenue, USD Billion, 2018 – 2030)
- Cell sourcing & isolation
- Culture & cryopreservation
- Cells & cell lines
- Kits, media, & reagents
Mesenchymal Stem Cells Market, Type Outlook (Revenue, USD Billion, 2018 – 2030)
Mesenchymal Stem Cells Market, Source of Isolation Outlook (Revenue, USD Billion, 2018 – 2030)
- Bone Marrow
- Cord Blood
- Peripheral Blood
- Fallopian Tube
- Fetal liver
- Adipose tissues
Mesenchymal Stem Cells Market, Indication Outlook (Revenue, USD Billion, 2018 – 2030)
- Bone and cartilage repair
- Cardiovascular disease
- Inflammatory & immunological diseases
- Liver diseases
Mesenchymal Stem Cells Market, Application Outlook (Revenue, USD Billion, 2018 – 2030)
- Disease modeling
- Drug development & discovery
- Stem cell banking
- Tissue engineering
- Toxicology studies
Mesenchymal Stem Cells Market, Regional Outlook (Revenue, USD Billion, 2018 – 2030)
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa